Literature DB >> 31742121

Potential antimicrobial properties of streptomyces isolated from Sammuk Mountain soil, Chonburi Province, Thailand.

Paranee Sripreechasak1, Anan Athipornchai2.   

Abstract

An infection of pathogenic microorganisms can create a big problem for human health. This has triggered the need for discovery and development of antibiotic drugs with altered modes of action. Approximately 45% of antibiotic drugs are derived from Streptomyces, which are the most commonly isolated actinomycete genera. The present investigation aimed to search for and study antimicrobial-producing actinomycetes isolated from soil samples from Sammuk Mountain, Chonburi province, Thailand. A total of 50 isolates from six soil samples were obtained and their actinomycetes were better isolated using humic acid-vitamin agar medium (64.0%) than starch casein nitrate agar medium (36.0%). In addition, the secondary metabolites produced from 13 isolates (26.0%) exhibited a broad spectrum of antimicrobial activity against Gram-positive bacteria and yeast. Thus, Sammuk Mountain soil is an important source of antibiotic-producing actinomycetes. Copyright:
© 2019 Journal of Advanced Pharmaceutical Technology & Research.

Entities:  

Keywords:  Actinomycetes; antibiotic; antimicrobial activity; multidrug resistant

Year:  2019        PMID: 31742121      PMCID: PMC6844005          DOI: 10.4103/japtr.JAPTR_55_19

Source DB:  PubMed          Journal:  J Adv Pharm Technol Res        ISSN: 0976-2094


INTRODUCTION

Diseases caused by infections of pathogenic microorganisms such as diarrhea, gastrointestinal and urogenital diseases, and wound contamination are increasing and becoming a problem for human health because of the emergence of multidrug-resistant pathogens.[1] It has been estimated that the multidrug-resistant Gram-positive and Gram-negative bacteria such as Enterobacteriaceae (carbapenem) and Enterococcus (vancomycin) together with Salmonella enterica, Staphylococcus aureus (methicillin), Pseudomonas aeruginosa, Clostridium difficile, and Escherichia coli could cause up to 10 million deaths/annum by 2050.[2] This has triggered the need for the discovery and development of antibiotic drugs with altered modes of action. Natural products, including plants, microorganisms, and their compounds, have been utilized to treat and cure several diseases such as diarrhea, cancer, diabetes, Alzheimer's, anti-inflammatory, analgesic and antipyretic solutions, and as alternatives for hormone replacement therapy.[34] In particular, microorganisms have an ability to produce a wide variety of bioactive metabolites, especially antibiotic agents. It has been recently reported that over 10,000 bioactive natural antibiotics such as penicillin, tetracycline, gentamicin, vancomycin, and pimaricin obtained from microbes were produced by actinomycetes.[567] These are an extensive and diverse group of Gram-positive aerobic bacteria usually grow by filament formation, and they are one of the major microbial populations present in soils.[8] Moreover, approximately 45% of these agents derived from Streptomyces which are the most commonly isolated actinomycete genera. Therefore, actinomycetes play an important natural resources role for producing new antimicrobial agents. In 2014, Sripreechasak et al. reported the isolation and identification of Streptomyces strains which were isolated from 13 soil samples collected around the Angthong Islands National Park, Thailand. All isolated Streptomyces were screened and evaluated for antimicrobial activity. All of these strains showed good inhibitory activity against Bacillus subtilis ATCC 6633, Kocuria rhizophila ATCC 9341, Mucor racemosus IFO 4581, Candida albicans KF1, E. coli NIHJ KB213, and Xanthomonas campestris pv. oryzae KB88.[9] They also reported the isolation of two new naphthoquinones and 17 known metabolites from Streptomyces sp. BCC71188 isolated from soil. Some of the isolated compounds showed strong antimicrobial activities such as antimalarial, anti-tuberculosis and antibacterial activities, and cytotoxicity against MCF-7, KB, and NCI-H187.[10] In an attempt to address the serious public health problem of the infectious disease, the present investigation aimed to search for and study antimicrobial-producing actinomycetes from soil samples from Sammuk Mountain, Chonburi province, Thailand.

MATERIALS AND METHODS

Sample processing and isolation of actinomycetes

Six soil samples were collected around Sammuk Mountain (SM1-6), Chonburi province, Thailand. The samples were dried by heating at 100°C for 1 h, suspended in basic lauryl-sulfate buffer solution and heated at 60°C for 5 min. Serial 10-fold dilutions of the suspension were prepared and 0.1 mL of 10−2, 10−3 and 10−4 dilutions were spread on the surface of starch casein nitrate agar (SCN agar: starch 0.1%, sodium caseinate 0.03%, KNO30.2%, and agar 1.5%, pH 7.0) and humic acid-vitamin agar (HV agar: humic acid 0.1%, Na2 HPO40.05%, KCl 0.17 g, MgSO4.7H2O 0.005%, FeSO4.7H2O 0.001 g, CaCl20.1%, B-Vitamins including 0.05% each of thiamine-hydrochloride, riboflavin, niacin, pyridoxine, capantothenate, inositol, p-aminobenzoic acid, and 0.025% of biotin and agar 1.8% g, pH 7.4). Each agar plate was supplemented with antibiotics, 50 mg/L of cycloheximide and 20 mg/L of nalidixic acid. The different colonies were picked up after incubation at room temperature for 14 days, and these plates were streaked for further purification on yeast extract-malt extract agar (International Streptomyces Project (ISP) medium no. 2).[11] The pure isolates were observed for their cultural characteristics after cultivation on ISP 2 agar (yeast extract 4.0%, malt extract 10.0%, dextrose 4.0%, and agar 20.0%, pH 7.3) at 28°C for 2 weeks. All pure isolates were kept in 20% (v/v) glycerol solution at −20°C until further use.

Screening of antimicrobial activity of pure isolates

The pure isolates were screened for antimicrobial activity against six microorganisms, including B. subtilis ATCC 6633, Micrococcus luteus ATCC 9341, S. aureus ATCC 25925, P. aeruginosa ATCC 27853, C. albicans ATCC 10231, and E. coli ATCC 25922 using the perpendicular streak method on ISP 2 agar medium.[1213] The results were conducted in triplicate and averaged. All pathogenic microorganisms were kindly supplied by Prof. Dr. Somboon Tanasupawat, Department of Biochemistry and Microbiology, Faculty of Pharmaceutical Science, Chulalongkorn University.

Morphological characterization and identification of active isolates

All pure isolates were inoculated on ISP 2 media and incubated for 14 days at room temperature. Colony morphology was observed under a microscope and color, aerial and substrate mycelium were noted.[1415] The 16S rRNA gene was amplified using the primers described by Takahashi et al.[16] The polymerase chain reaction products were checked by agarose gel electrophoresis and directly sequence using a BigDye ® Terminator V3.1 cycle sequencing kit (Applied Biosystems), according to the manufacturer's instructions.

Antimicrobial metabolites production of pure isolates

Each isolate was cultured in ISP 2 medium and shaken (150 rpm) at room temperature for 3 days. Two percent of the ISP 2 culture was transferred into 200 mL of new ISP 2 medium and also cultivated on a shaker for 9 days. The cultured broth was then evaluated for antimicrobial activity using an agar well diffusion assay.[1718] All analyses in this study were performed in three replicates.

RESULTS AND DISCUSSION

Isolation and characterization of the isolates

As shown in the supporting information [Table S1], a total of 50 isolates obtained from six soil samples collected from Sammuk Mountain were studied. Actinomycetes cultures were isolated more using HV agar medium (64.0%) than SCN agar medium (36.0%). Thus, HV agar medium was found to be suitable for isolating actinomycetes from these soil samples. Table 1 summarizes the morphological patterns of the active isolates actinomycetes. All of the isolates growth was found to be in good condition and showed the color appearance of individual isolates. The 16S rDNA sequence was generated for most potent isolates. Comparison of this nucleotide sequence with members of actinomycetes clearly showed that these strains belong to the genus Streptomyces.
Table S1

Morphological analysis of all actinomycetes isolates

NumbersIsolatesGrowthAerial myceliumSubstrate myceliumSoluble pigment
1SM1-HV1GoodPale yellowish pinkVivid orange yellowNone
2SM1-HV2GoodLight orangeStrong orange yellowNone
3SM1-HV3GoodYellowish whiteModerate yellowNone
4SM1-HV4GoodOlive blackDark grayish oliveGrayish greenish yellow
5SM1-HV5GoodLight grayLight olive brown - moderate olive brownDark yellow
6SM1-HV6GoodBlackish purpleVery dark reddish purpleGrayish reddish brown
7SM1-HV7GoodPale yellowLight yellowNone
8SM1-SCN8GoodLight purplish gray - light grayDeep brown - deep yellowish brownStrong yellowish brown
9SM1-SCN9GoodGrayish yellow - dark grayish yellowGrayish yellow - dark grayish yellowNone
10SM1-SCN10GoodMedium grayModerate brown - light grayish oliveNone
11SM1-SCN11GoodLight gray - medium grayDark yellowNone
12SM2-HV1GoodMedium grayGrayish yellow - dark grayish yellowNone
13SM2-HV2GoodWhite - bluish grayStrong grayish yellow - deep grayish yellowNone
14SM2-HV4GoodLight brownish grayModerate oliveGrayish greenish yellow
15SM2-HV8GoodGreenish white - medium grayLight yellowGrayish greenish yellow
16SM2-SCN5GoodModerate olive brownModerate olive brownLight greenish yellow
17SM2-SCN6Goodgrayish yellow - medium grayModerate greenish yellowNone
18SM3-HV1GoodGreenish white - medium grayGrayish yellow - light grayish oliveNone
19SM3-HV2GoodGreenish whiteDeep yellowish brownDark yellow
20SM3-HV3GoodModerate olive brownLight olive brownLight olive brown
21SM3-HV4GoodGreenish white - medium grayPale yellowish green - light grayish olivePale yellowish green
22SM3-SCN5GoodMedium grayDark grayish yellowLight yellowish brown
23SM3-SCN6GoodMedium grayLight grayish olive and brownish orangeGrayish greenish yellow
24SM3-SCN7GoodMedium grayModerate oliveGrayish greenish yellow
25SM3-SCN8GoodLight brownish grayDark brownDeep yellowish brown
26SM3-SCN10GoodGrayish greenish yellowDark grayish yellowNone
27SM3-SCN11GoodGrayish yellowDark yellowGrayish greenish yellow
28SM4-HV1GoodYellowish grayLight orange yellow - strong yellowish brownModerate yellow
29SM4-HV2GoodBluish grayModerate olive brownGrayish greenish yellow
30SM4-HV4GoodWhite - medium grayPale yellowish green - moderate oliveGrayish greenish yellow
31SM4-HV5GoodStrong yellowBrilliant yellow - strong yellowBrilliant greenish yellow
32SM4-HV6GoodYellowish white - pale orange yellowModerate yellowNone
33SM4-HV7GoodLight gray - olive grayGrayish olive - dark oliveGrayish olive
34SM4-HV8GoodYellowish whiteStrong yellowish brownDark orange yellow
35SM4-SCN9GoodMedium grayLight grayish olive - moderate oliveNone
36SM4-SCN10GoodLight orangeModerate orange yellowNone
37SM4-SCN11GoodPinkish whiteModerate yellowNone
38SM4-SCN12GoodGreenish whiteDeep yellowNone
39SM5-HV1GoodWhite - greenish whiteDark yellowNone
40SM5-HV2GoodMedium grayLight grayish orangeNone
41SM5-HV3GoodLight orange yellowModerate yellowNone
42SM5-HV4GoodMedium grayDark grayish yellowGrayish greenish yellow
43SM5-HV5GoodVivid orangeStrong orange yellowNone
44SM5-HV7GoodBluish grayGrayish olive greenLight grayish olive
45SM5-HV8GoodBluish grayGrayish olive greenLight grayish olive
46SM6-HV1GoodPale blue - blackish purpleBlackish purpleVery dark reddish purple
47SM6-HV2GoodWhite - greenish whitePale yellowish greenNone
48SM6-HV3Light olive gray - olive grayModerate olive brownModerate olive brown
49SM6-SCN4Light bluish gray - greenish grayDark grayish yellow - moderate olive brownNone
50SM6-SCN5Pale blue - blackish purpleBlackish purpleVery dark reddish purple

SCN: Starch casein nitrate, HV: Humic vitamin

Table 1

Morphological analysis of active actinomycetes isolates

NumbersIsolatesGrowthAerial myceliumSubstrate myceliumSoluble pigment
1SM1-HV5GoodLight grayLight olive brown - moderate olive brownDark yellow
2SM1-SCN8GoodLight purplish gray - light grayDeep brown - deep yellowish brownStrong yellowish brown
3SM2-HV1GoodMedium grayGrayish yellow - dark grayish yellowNone
4SM2-HV4GoodLight brownish grayModerate oliveGrayish greenish yellow
5SM2-HV8GoodGreenish white - medium grayLight yellowGrayish greenish yellow
6SM2-SCN5GoodModerate olive brownModerate olive brownLight greenish yellow
7SM3-HV2GoodGreenish whiteDeep yellowish brownDark yellow
8SM3-SCN7GoodMedium grayModerate oliveGrayish greenish yellow
9SM4-HV1GoodYellowish grayLight orange yellow - strong yellowish brownModerate yellow
10SM4-HV2GoodBluish grayModerate olive brownGrayish greenish yellow
11SM4-HV5GoodStrong yellowBrilliant yellow - strong yellowBrilliant greenish yellow
12SM4-HV7GoodLight gray - olive grayGrayish olive - dark oliveGrayish olive
13SM4-HV8GoodYellowish whiteStrong yellowish brownDark orange yellow
14SM4-SCN9GoodMedium grayLight grayish olive - moderate oliveNone
15SM6-HV1GoodPale blue - blackish purpleBlackish purpleVery dark reddish purple
16SM6-SCN4GoodLight bluish gray - greenish grayDark grayish yellow - moderate olive brownNone
17SM6-SCN5GoodPale blue - blackish purpleBlackish purpleVery dark reddish purple

SCN: Starch casein nitrate, HV: Humic vitamin

Morphological analysis of all actinomycetes isolates SCN: Starch casein nitrate, HV: Humic vitamin Morphological analysis of active actinomycetes isolates SCN: Starch casein nitrate, HV: Humic vitamin

Antimicrobial activity of the isolates

On screening all of the isolates for antimicrobial activity, using the perpendicular streak method on ISP 2 agar medium, 13 isolates (26.0%) showed strong inhibitory activity against human pathogens [Table 2]. The isolate SM2-HV8 showed good inhibition against C. albicans with the inhibition zone being 15.0 ± 0.00 mm, whereas SM6-SCN5 showed inhibitory activity against Gram-negative bacteria, P. aeruginosa (8.0 ± 1.00 mm).
Table 2

Antimicrobial activity of the isolates using the perpendicular streak method

NumbersIsolatesZone of inhibition (mm)
Gram-positive bacteria
Gram-negative bacteria
YeastCandida albicans
Bacillus subtilisMicrococcus luteusStaphylococcus aureusPseudomonas aeruginosaEscherichia coli
1SM2-HV1-16.7±0.58----
2SM2-HV445.0±1.0012±1.00----
3SM2-HV8-----15.0±0.00
4SM2-SCN533.0±1.0025.0±1.00----
5SM3-SCN738.3±4.0441.3±3.0627.3±2.08---
6SM4-HV122.3±2.5122.3±1.5318.3±3.51---
7SM4-HV212.7±0.5816.0±1.0010.0±1.00---
8SM4-HV537.3±6.6637.3±9.4543.0±12.12---
9SM4-HV749.0±3.60-42.3±2.52---
10SM4-HV829.0±1.0037.3±2.5138.3±4.72---
11SM4-SCN921.0±1.0028.0±1.00----
12SM6-SCN445.0±1.0040.0±1.0045.0±1.00---
13SM6-SCN55.0±1.0011.7±1.53-8.0±1.00--

SCN: Starch casein nitrate, HV: Humic vitamin

Antimicrobial activity of the isolates using the perpendicular streak method SCN: Starch casein nitrate, HV: Humic vitamin The isolates were then fermented in ISP 2 medium to produce the secondary metabolites. The cultured broths were evaluated for their antimicrobial activity using an agar well diffusion assay and the results are shown in Table 3. Thirteen isolates (26.0%) out of 50 actinomycetes exhibited a broad spectrum of antimicrobial activity against Gram-positive bacteria. The isolates SM1-HV5 and SM1-SCN8 specifically inhibited against C. albicans with the inhibition zone being 8.7 ± 0.58 and 10.0 ± 1.00 mm, respectively.
Table 3

Antimicrobial activity of secondary metabolites produced from actinomycetes

NumbersIsolatesZone of inhibition (mm)
Gram-positive bacteria
Gram-negative bacteria
YeastCandida albicans
Bacillus subtilisMicrococcus luteusStaphylococcus aureusPseudomonas aeruginosaEscherichia coli
1SM1-HV516.3±0.5820.3±0.5815.3±0.58--8.7±0.58
2SM1-SCN816.7±0.5820.0±0.0015.8±0.29--10.0±1.00
3SM2-HV1-12.0±0.00----
4SM2-HV49.2±0.29-----
5SM2-SCN59.3±0.58-14.3±1.15---
6SM3-HV2-17.0±0.0018.0±0.00---
7SM3-SCN7-9.0±0.00----
8SM4-HV213.0±0.0014.7±0.5813.0±0.00---
9SM4-HV512.7±0.5812.2±0.29----
10SM4-HV8-11.2±0.29----
11SM4-SCN98.8±0.2912.0±0.00----
12SM6-HV18.8±0.29-----
13SM6-SCN49.0±0.009.0±0.0011.5±0.50---

SCN: Starch casein nitrate, HV: Humic vitamin

Antimicrobial activity of secondary metabolites produced from actinomycetes SCN: Starch casein nitrate, HV: Humic vitamin In addition, all isolates could not inhibit Gram-negative bacteria, P. aeruginosa and E. coli. As shown in Figure 1, all isolates showed moderate-to-high inhibitory activity to M. luteus (79.92%), B. subtilis (69.23%) and S. aureus (46.15%), whereas their isolates showed moderate activity against C. albicans (15.38%). The isolates obtained from HV agar medium were more active than from SCN agar medium, as shown in Figure 2. Thus, actinomycetes isolated from HV agar medium could be suitable for producing bioactive metabolites against Gram-positive bacteria. This result was confirmed by Hayakawa and Nonomura[19] who found that HV agar medium supported adequate growth and good sporulation for these actinomycetes because it contained soil humic acid as the sole source of carbon and nitrogen.
Figure 1

Antimicrobial activity of secondary metabolites produced from actinomycetes

Figure 2

Antimicrobial activity of actinomycetes isolated by using humic vitamin and starch casein nitrate medium

Antimicrobial activity of secondary metabolites produced from actinomycetes Antimicrobial activity of actinomycetes isolated by using humic vitamin and starch casein nitrate medium

CONCLUSIONS

Of the 50 isolates obtained from six soil samples, 64.0% of their actinomycetes were isolated using HV agar medium compared to 36.0% using SCN agar medium. The HV agar medium contained soil humic acid as the sole source of carbon and nitrogen. In addition, the secondary metabolites produced from 13 isolates (26.0%) exhibited a broad spectrum of antimicrobial activity against Gram-positive bacteria and yeast. Thus, Sammuk Mountain soil from Chonburi province, Thailand, is an important source for exploration of antibiotic-producing actinomycetes.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  9 in total

1.  Well diffusion for antifungal susceptibility testing.

Authors:  S Magaldi; S Mata-Essayag; C Hartung de Capriles; C Perez; M T Colella; Carolina Olaizola; Yudith Ontiveros
Journal:  Int J Infect Dis       Date:  2004-01       Impact factor: 3.623

Review 2.  Cimicifugae rhizoma: from origins, bioactive constituents to clinical outcomes.

Authors:  Jian-Xin Li; Zhi-Yong Yu
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

Review 3.  Multidrug resistant (or antimicrobial-resistant) pathogens - alternatives to new antibiotics?

Authors:  Anne-Sophie Brunel; Benoit Guery
Journal:  Swiss Med Wkly       Date:  2017-11-22       Impact factor: 2.193

4.  Investigation on antimicrobial agents of the terrestrial Streptomyces sp. BCC71188.

Authors:  Khomsan Supong; Paranee Sripreechasak; Somboon Tanasupawat; Kannawat Danwisetkanjana; Pranee Rachtawee; Pattama Pittayakhajonwut
Journal:  Appl Microbiol Biotechnol       Date:  2016-08-23       Impact factor: 4.813

5.  Streptomyces avermectinius sp. nov., an avermectin-producing strain.

Authors:  Yoko Takahashi; Atsuko Matsumoto; Akio Seino; Junji Ueno; Yuzuru Iwai; Satoshi Omura
Journal:  Int J Syst Evol Microbiol       Date:  2002-11       Impact factor: 2.747

6.  Evaluation with receptor binding assay on the water extracts of ten CNS-active Chinese herbal drugs.

Authors:  J F Liao; Y M Jan; S Y Huang; H H Wang; L L Yu; C F Chen
Journal:  Proc Natl Sci Counc Repub China B       Date:  1995-07

7.  The antibacterial activity of extracts of nine plant species with good activity against Escherichia coli against five other bacteria and cytotoxicity of extracts.

Authors:  Ishaku Leo Elisha; Francien S Botha; Lyndy Joy McGaw; Jacobus Nicolaas Eloff
Journal:  BMC Complement Altern Med       Date:  2017-02-28       Impact factor: 3.659

8.  Isolation of antimicrobial producing Actinobacteria from soil samples.

Authors:  Afaf Ahmed Elbendary; Ashgan Mohamed Hessain; Mahmoud Darderi El-Hariri; Ahmed Adel Seida; Ihab Mohamed Moussa; Ayman Salem Mubarak; Saleh A Kabli; Hassan A Hemeg; Jakeen Kamal El Jakee
Journal:  Saudi J Biol Sci       Date:  2017-05-06       Impact factor: 4.219

9.  Antimicrobial and enzymatic activity of actinomycetes isolated from soils of coastal islands.

Authors:  Ivana Charousová; Juraj Medo; Eva Halenárová; Soňa Javoreková
Journal:  J Adv Pharm Technol Res       Date:  2017 Apr-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.